These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26186456)

  • 41. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability of live attenuated rotavirus vaccine with selected preservatives and primary containers.
    Lal M; Jarrahian C; Zhu C; Hosken NA; McClurkan CL; Koelle DM; Saxon E; Roehrig A; Zehrung D; Chen D
    Vaccine; 2016 May; 34(22):2483-9. PubMed ID: 27085171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prefilled injection device for outreach tetanus immunization by Bolivian traditional birth attendants.
    Quiroga R; Halkyer P; Gil F; Nelson C; Kristensen D
    Rev Panam Salud Publica; 1998 Jul; 4(1):20-5. PubMed ID: 9734224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of immunization injections in Africa: not simply a problem of logistics.
    Dicko M; Oni AQ; Ganivet S; Kone S; Pierre L; Jacquet B
    Bull World Health Organ; 2000; 78(2):163-9. PubMed ID: 10743280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety monitoring of a new pentavalent vaccine in the expanded programme on immunisation in Ghana.
    Dodoo AN; Renner L; van Grootheest AC; Labadie J; Antwi-Agyei KO; Hayibor S; Addison J; Pappoe V; Appiah-Danquah A
    Drug Saf; 2007; 30(4):347-56. PubMed ID: 17408311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of missed opportunities for vaccination in Kenyan health facilities, 2016.
    Li AJ; Tabu C; Shendale S; Sergon K; Okoth PO; Mugoya IK; Machekanyanga Z; Onuekwusi IU; Sanderson C; Ogbuanu IU
    PLoS One; 2020; 15(8):e0237913. PubMed ID: 32817630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple cohort HPV vaccination in Zimbabwe: 2018-2019 program feasibility, awareness, and acceptability among health, education, and community stakeholders.
    Garon JR; Mukavhi A; Rupfutse M; Bright S; Brennan T; Manangazira P; An Q; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A30-A37. PubMed ID: 34144852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions.
    Salmon DA; Moulton LH; Omer SB; Chace LM; Klassen A; Talebian P; Halsey NA
    Pediatrics; 2004 Jun; 113(6):e552-9. PubMed ID: 15173536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.
    Hutubessy R; Levin A; Wang S; Morgan W; Ally M; John T; Broutet N
    BMC Med; 2012 Nov; 10():136. PubMed ID: 23146319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania.
    Watson-Jones D; Lees S; Mwanga J; Neke N; Changalucha J; Broutet N; Maduhu I; Kapiga S; Chandra-Mouli V; Bloem P; Ross DA
    Health Policy Plan; 2016 Jul; 31(6):691-9. PubMed ID: 26768827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.
    Mvundura M; Lorenson K; Chweya A; Kigadye R; Bartholomew K; Makame M; Lennon TP; Mwangi S; Kirika L; Kamau P; Otieno A; Murunga P; Omurwa T; Dafrossa L; Kristensen D
    Vaccine; 2015 May; 33(23):2697-703. PubMed ID: 25865467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination.
    Cover JK; Nghi NQ; LaMontagne DS; Huyen DT; Hien NT; Nga le T
    BMC Public Health; 2012 Aug; 12():629. PubMed ID: 22877158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010720. PubMed ID: 30091147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal.
    Johm P; Nkoum N; Ceesay A; Mbaye EH; Larson H; Kampmann B
    Vaccine; 2021 Jun; 39(29):3926-3934. PubMed ID: 34088509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A global health partnership's use of time-limited support to catalyze health practice change: the case of GAVI's Injection Safety Support.
    Levin A; Fang A; Hansen PM; Pyle D; Dia O; Schwalbe N
    PLoS One; 2010 Sep; 5(9):e12986. PubMed ID: 20885995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intradermal delivery for vaccine dose sparing: overview of current issues.
    Zehrung D; Jarrahian C; Wales A
    Vaccine; 2013 Jul; 31(34):3392-5. PubMed ID: 23176978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccine safety monitoring systems in developing countries: an example of the Vietnam model.
    Ali M; Rath B; Thiem VD
    Curr Drug Saf; 2015; 10(1):60-7. PubMed ID: 25859677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Equity and immunization supply chain in Madagascar.
    van den Ent MMVX; Yameogo A; Ribaira E; Hanson CM; Ratoto R; Rasolomanana S; Foncha C; Gasse F
    Vaccine; 2017 Apr; 35(17):2148-2154. PubMed ID: 28364923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of childhood immunizations in Senegal: Adding previous shots to sociodemographic background.
    Peretti-Watel P; Cortaredona S; Ly EY; Seror V; Ndiaye S; Gaye I; Fall M
    Hum Vaccin Immunother; 2020; 16(2):363-370. PubMed ID: 31567044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.